$FTRE

SANDERS MACHELLE sold $175K of FTRE

SANDERS MACHELLE sold 9,700 shares of Fortrea Holdings Inc. (FTRE) at $18.01 ($0.17M total) on 2026-08-03.

Original reporting
SEC EDGAR · SANDERS MACHELLE
Published Aug 5, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:29 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FTRE
Neutral
low confidence
Mentioned
$FTRE
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FTRENeutralLow
01

Why it matters

The disclosure updates the record of insider ownership and may influence short-term sentiment, but it does not include any new company fundamentals.

02

Market read

Traders may note insider selling, but absent additional fundamental catalysts, the event is unlikely to drive a major repricing.

03

What to watch

The article does not state whether the sale was part of a 10b5-1 plan (it says no), but it also provides no context on motivations or other concurrent insider activity.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-05, transaction dated 2026-08-03

Background

This is a SEC Form 4 insider transaction disclosure for Fortrea Holdings Inc.

Company-level read

Ticker impact

$FTRENeutralLow confidence
Context

Fortrea director Sanders Machelle filed a Form 4 selling 9,700 shares at $18.01 on 2026-08-03, totaling about $174.7K.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted unless accompanied by other disclosures.

Evidence & confidence

The filing is an insider transaction without a 10b5-1 plan and is relatively small versus typical company market caps, with no accompanying operational or guidance change disclosed.

Market effects

No clear sector read-through from a single, small insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs, so the signal may be noise.

Key entities

  • Fortrea Holdings Inc.

    Subject of the Form 4 insider sale by a director.

  • SANDERS MACHELLE

    Director who sold 9,700 shares in an open-market transaction.

Related articles

$FTREHighAI 9/10

Fortrea Q2 Earnings Call Highlights

"The environment has become more supportive, but our results are not simply the result of market recovery," Thakral said, attributing the performance to changes in commercial execution, including improved global coordination, a sharper focus on opportunities where the company can compete effectively and a clearer approach to serving distinct customer segments. Thakral said Fortrea's clinical pharmacology services business was a particular area of strength.

$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Reports Strong Q2 CY2026, Full

Fortrea Holdings (NASDAQ:FTRE) reported Q2 CY2026 revenue of $678.2 million, down 4.5% year over year but 4.7% above market expectations, according to the company. Full-year revenue guidance was $2.66 billion at the midpoint, 1.8% above analysts’ estimates. Non-GAAP EPS was $0.23, 27.2% above consensus.

$FTREMed

Fortrea Holdings Inc. (FTRE): Results of Operations and Financial Condition

Fortrea Holdings Inc. (FTRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-pressreleasedat.htm EX-99.1 Document Exhibit 99.1 Fortrea Reports Second Quarter 2026 Results Four consecutive quarters of execution to drive commercial, operational and financial excellence Increases full-year guidance Highlights For the three months ended J

$FTREMedAI 8/10

Fortrea (NASDAQ:FTRE) Trading 10.5% Higher – Should You Buy?

Fortrea Holdings (NASDAQ:FTRE) rose 10.5% in mid-day trading Thursday, reaching $17.20 and last at $17.27, after closing at $15.63. Volume was 886,991 shares, down 42% vs. average. Analysts cited include price targets from $14 to $20. On May 5, Fortrea reported $0.16 EPS vs $0.03 expected and $636.5M revenue vs $628.5M.

$FTREMed

Fortrea (NASDAQ:FTRE) Trading 10.5% Higher – Should You Buy?

Fortrea Holdings (FTRE) rose 10.5% mid-day Thursday, trading between $17.20 and $17.27 after closing at $15.63. Volume was 886,991 shares, down 42% from average. Analysts cited include Mizuho (neutral, $13), Citigroup (buy, $20) and others; consensus is Hold with $17.25 average target. On May 5, Fortrea reported $0.16 EPS and $636.5M revenue.